the paracortical area, until, at the lepromatous pole, these areas are completely replaced. As the macrophages become more and more undifferentiated they are found to be carrying an increasing load of Mycobacteria which they appear to be unable to eliminate.
Granuloma Formation in
Thymus-dependent Areas ofLymph Nodes Depleted ofSmall Lymphocytes Depletion of the paracortical or thymusdependent areas of lymph nodes can be produced experimentally by depletion of the mobile pool of long-lived small lymphocytes by neonatal thymectomy or treatment with antilymphocyte serum. The depleted areas are infiltrated by undifferentiated cells of the reticulohistiocyte series. Lymph follicles, germinal centres and their marginal cuff of small lymphocytes and the plasma cells in the medullary cords and at the corticomedullary junction are unaffected and develop normally. Up to 5% of the infiltrating cells which are spindle shaped can be seen to take up 3H-thymidine within one hour of its injection. There may also be an increased amount of reticulin formed in relation to these cells. Such spindle cells or reticulohistiocytes contain a large number of acid-phosphatase-containing granules, resembling lysosomes.
Similar cells have been found replacing the paracortical areas of babies who die with congenital thymic aplasia (Nezelof et al. 1964 ). It has therefore been suggested (Turk & Oort 1970 ) that paracortical areas may have a dual potentiality. Under normal conditions there is proliferation of lymphocytes. However, if proliferation of lymphocytes is inhibited by a depletion of the mobile pool of long-lived lymphocytes, a second potential becomes apparent which is the proliferation of reticulohistiocytes. Such a dual potential could account for the fact that in human pathology one can observe paracortical areas showing predominant lymphocyte hyperplasia and in other conditions a mixture of lymphocytes and reticulohistiocytic cells.
Another condition, in which paracortical areas may be depleted of small lymphocytes and replaced by proliferating reticulohistiocytes, is the Wiskott-Aldrich syndrome. These changes occur in the later stages of the disease and are associated with deficiences in cell-mediated immunity. Germinal centres and plasma cells are normal. In many lymph nodes and spleens from these patients the accumulation of reticulum cells may be so extensive as to suggest that this response might underlie the widespread reticulum or lymphoreticular malignancies which have been shown to occur in some patients with this disease (Cooper et al. 1968 (Sutherland et al. 1965 , Mitchell et al. 1968 ). Moreover, among patients with a recent acute symptomatic onset of sarcoidosis and among those presenting with symptomless bilateral hilar lymphadenopathy, rather less than half are negative reactors to 100 tuberculin units (TU) (PPD) (Lofgren & Lundbiick 1952 , Wurm 1963 , Scadding 1967 ). Most observers (Blackburn et al. 1939 , Williams 1965 , Phear 1958 have found that patients with Crohn's disease show a high incidence of negative tuberculin reactions, but Fletcher & Hinton (1967) in a carefully controlled study failed to confirm this. The results of a current study, which includes skin tests with tuberculin (10 TU and 100 TU PPD Weybridge) and with Candida albicans antigens (a 1/1,000 dilution of a heat-killed Candida albicans suspension) thus far show only a marginal defect of cutaneous delayedtype hypersensitivity among these patients (Mitchell, Cannon, Dyer, Hinson & Willoughby, to be published).
The Kveim test, a skin reaction of 'delayed, delayed-type' (Hart & Rees 1967) is positive in the majority (60-90%) of patients with recent sarcoidosis (Siltzbach 1961 , Mitchell, Sutherland & Bradstreet 1971 , Hurley 1971 , Mikhail & Mitchell 1970 , the proportion of negative reactions increasing with the duration of the disease. Recently, positive Kveim tests with microscopic appearances typical of the Kveim reaction in sarcoidosis have been encountered among a substantial proportion (50 %) of patients with active or recently active Crohn's disease who were not receiving treatment with steroids during the period of Kveim testing. Moreover, closely similar results were obtained following tests with carefully validated suspensions prepared from two different lots of spleen K12 and following simultaneous tests with K12 and with another widely used (Hurley) test suspension (Mitchell, Cannon, Dyer, Hinson & Willoughby 1969 . More recently, Karlish et al. (1970) , using Hurley's test suspension, reported microscopically positive Kveim tests among a similarly high proportion of patients with clinically active Crohn's disease who had not received steroids.
We recently reported the results of carefully controlled animal experiments in which evidence of a transmissible agent from human sarcoid tissue (Mitchell & Rees 1969 ) was demonstrated, as was the presence of a transmissible agent from Crohn's disease (Mitchell & Rees 1970) . Human sarcoid and Crohn's tissue homogenates were injected into the footpads of normal and immunologically deficient mice; epithelioid and giant cell granulomas were found in the footpads of these mice 169-500 days following injection. The footpads of mice given identically prepared 'control' homogenates derived from several normal lymph nodes showed only nonspecific inflammatory changes. Microscopically positive Kveim tests were found following tests given at intervals of between 42 and 500 days after footpad inoculation. These positive Kveim tests were confined to mice given sarcoid or Crohn's tissue homogenates and were all associated with epithelioid and giant cell granulomas in the footpad. Kveim tests in the ears of all mice receiving 'control' homogenates were uniformly negative. Two of the ten normal mice which had been inoculated with Crohn's tissue homogenates, and subsequently killed more than 600 days later, showed granulomatous changes in the bowel wall of the terminal ileum. Both showed focal granulomas in the footpad and were Kveim positive.
Homogenates were prepared in an identical manner from mouse footpad tissues showing epithelioid and giant cell granulomas 553-603 days following the injection of human sarcoid and of Crohn's tissue homogenates and, as controls, from the footpad tissues of mice receiving homogenates derived from normal human lymph nodes after the same intervals following footpad inoculation. Each homogenate was again injected into the footpads of normal and immunologically deficient mice. Thus far, epithelioid and giant cell granulomas have again been found in a substantial proportion of the footpads of both normal and immunologically deficient mice receiving 'sarcoid' or 'Crohn's' mouse footpad tissue homogenates 151-365 days after footpad inocula-tion; whereas mice given 'control' mouse footpad tissue homogenates showed only nonspecific inflammatory changes. Microscopically positive Kveim tests were again found in the ears of a proportion of mice given mouse 'sarcoid' footpad or mouse 'Crohn's' footpad homogenates and were all associated with epithelioid and giant cell granulomas in the footpad. In contrast, Kveim tests in the ears of all mice receiving 'control' mouse footpad tissue homogenates were negative.
Positive Kveim tests in sarcoidosis and Crohn's disease might be accounted for by the prior exposure of patients with either condition to a similar or identical antigen, but the results of our animal experiments suggest that both diseases might share the same or a similar etiological agent.
Summary
(1) The onset of intrathoracic sarcoidosis among healthy young adults is unrelated to their previous tuberculin test status. BCG or vole bacillus vaccination does not promote or protect against the onset of sarcoidosis. Among patients with sarcoidosis, evidence of marked impairment of cell-mediated cutaneous hypersensitivity is less frequently found in those with a recent acute symptomatic onset or with asymptomatic bilateral hilar lymphadenopathy. Among patients with recently active Crohn's disease, only a marginal defect of cutaneous cell-mediated hypersensitivity has so far been found following tests with PPD tuberculin and with a heat-killed Candida albicans suspension.
(2) Kveim tests, using two extensively validated test suspensions derived from different sarcoid spleens (K12 and Hurley) yield closely similar results with a high proportion (50%) of microscopically positive results among patients with recently active Crohn's disease who have not received corticosteroids.
(3) The results of carefully controlled animal experiments have demonstrated a transmissible agent for mice from both human sarcoid and Crohn's disease tissues. A successful first passage of this agent in mice for both diseases has been obtained.
(4) The implications of these findings are discussed.
Dr W Jones Williams (Pathology Department, Welsh National School ofMedicine, Royal Infirmary, Cardiff)
The Beryllium Granuloma Beryllium disease may exist as two main entities, acute and chronic. The acute form, nonspecific chemical pneumonitis, was first described by Weber & Englehardt (1933) and the chronic form by Hardy & Tabershaw (1946) under the name granulomatous pneumonitis. Occasionally (Freiman & Hardy 1970), the acute disease progresses to the chronic variety. Most cases result from inhalation exposure and thus primarily affect the lungs. It must be stressed, however, that the condition is a systemic disease and affects other organs: skin, eyes, nose, heart, bones, liver and kidneys. Beryllium disease may also affect the skin alone (Tepper et al. 1961) . Hypersensitivity plays an important role and there is often a disparity between the concentration of beryllium in the tissue and the severity of the disease, and frequently a latent interval between exposure and onset. Skin reactions to beryllium salts are common and individual susceptibility is prominent.
The majority of the early cases followed exposure to beryllium phosphors used in fluorescent lamps but since 1948 these compounds have not been used. Beryllium, however, is increasingly used in a large variety of industries (Table 1) and therefore continues to be an industrial hazard.
The reported American and some British cases have been catalogued by Hardy (1955, 1963) and  the pathological features of their series have been recently analysed (Freiman & Hardy 1970) . Jones Williams (1958) listed 6 cases in the British liter-ature and 16 have now been reported (Rogers 1957 , Jordan & Darke 1958 , Sneddon 1958 , Wood et al. 1958 , Sita-Lumsden 1959 , McCallum et al. 1961 , Norris & Peard 1963 , Jones Williams et aL. 1967 .
The length of exposure prior to development of the disease may be anything up to 23 years. The duration of the disease is often over ten years and the fatality rate about 35 % (Stoeckle et al. 1969) .
The criteria for diagnosis include known exposure, compatible clinical features, presence of granulomas, detection of beryllium in the tissues and urine and a positive patch test. Kveim tests are uniformly negative, and tuberculin tests often negative (Stoeckle et aL 1969) . Beryllium patch tests (2% BeSO4) are usually positive (Curtis 1959) .
The present report is concerned with the chronic or granulomatous form of the disease.
Pathology
The characteristic hallmark of chronic beryllium disease is the sarcoid-like epithelioid cell granuloma with identical appearance in different tissues. In the lungs granulomas are found in the interstitial tissue, with a distribution similar to that in sarcoidosis. Nonspecific interstitial infiltration of histiocytes, lymphocytes and plasma cells is usually present which, together with the granulomas, contributes to progressive interstitial fibrosis, sometimes cystic change and terminal cor pulmonale. Freiman & Hardy (1970) have stressed that interstitial inflammation is associated with increased mortality.
Granulomas may also be found in other organs and in hilar lymph nodes but bilateral lymphadenopathy is unusual.
The granulomas consist of foci of epithelioid and giant cells with usually slight or absent central necrosis, together with admixture of lymphocytes and plasma cells most prominent at the periphery. Organisms are absent. Inclusion bodies, including Schaumann and asteroid bodies, may be found in both epithelioid and giant cells.
On light microscopy the morphology (Jones Williams 1958) , the histochemistry (Jones Williams & Williams 1967) and the enzyme con- Table 1 Occupations at risk (1) Fluorescent lamps accounted for the majority of the early cases (beryllium has not been used for this purpose since 1948) (2) Cathode tubes and X-ray machine windows (3) Alloys: Copper, copper aluminium, copper zinc, stainless steel, nickel, chromium (4) Ceramics (5) Beryllium extraction from ore (6) Experimental workers (7) Atomic energy. Source of neutrons (8) Neighbourhood cases: Population living 'down wind' ofberyllium factories, wives of workers
